1237 related articles for article (PubMed ID: 31755218)
41. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
Yonemori M; Seki N; Yoshino H; Matsushita R; Miyamoto K; Nakagawa M; Enokida H
Cancer Sci; 2016 Sep; 107(9):1233-42. PubMed ID: 27355528
[TBL] [Abstract][Full Text] [Related]
42. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2018 Sep; 109(9):2919-2936. PubMed ID: 29968393
[TBL] [Abstract][Full Text] [Related]
43. Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
Toda H; Kurozumi S; Kijima Y; Idichi T; Shinden Y; Yamada Y; Arai T; Maemura K; Fujii T; Horiguchi J; Natsugoe S; Seki N
J Hum Genet; 2018 Dec; 63(12):1197-1210. PubMed ID: 30228364
[TBL] [Abstract][Full Text] [Related]
44. Consistency analysis of microRNA-arm expression reveals microRNA-369-5p/3p as tumor suppressors in gastric cancer.
Dong L; Zhang Z; Xu J; Wang F; Ma Y; Li F; Shen C; Liu Z; Zhang J; Liu C; Yi P; Yu J
Mol Oncol; 2019 Jul; 13(7):1605-1620. PubMed ID: 31162777
[TBL] [Abstract][Full Text] [Related]
45. MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma.
Zhi F; Wang Q; Deng D; Shao N; Wang R; Xue L; Wang S; Xia X; Yang Y
PLoS One; 2014; 9(10):e109124. PubMed ID: 25299073
[TBL] [Abstract][Full Text] [Related]
46. The Molecular Pathogenesis of Tumor-Suppressive
Tomioka Y; Suetsugu T; Seki N; Tanigawa K; Hagihara Y; Shinmura M; Asai S; Kikkawa N; Inoue H; Mizuno K
Cells; 2023 Jul; 12(14):. PubMed ID: 37508549
[TBL] [Abstract][Full Text] [Related]
47. Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis.
Misono S; Seki N; Mizuno K; Yamada Y; Uchida A; Arai T; Kumamoto T; Sanada H; Suetsugu T; Inoue H
J Hum Genet; 2018 Oct; 63(10):1015-1028. PubMed ID: 30082847
[TBL] [Abstract][Full Text] [Related]
48. Impact of Oncogenic Targets Controlled by Tumor-Suppressive
Nepal P; Hozaka Y; Tanaka T; Wada M; Asai S; Minemura C; Idichi T; Arigami T; Kurahara H; Seki N; Ohtsuka T
Anticancer Res; 2021 Oct; 41(10):4821-4836. PubMed ID: 34593431
[TBL] [Abstract][Full Text] [Related]
49. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
[TBL] [Abstract][Full Text] [Related]
50. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
[TBL] [Abstract][Full Text] [Related]
51. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
53. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
54. Identification of Antitumor
Minemura C; Asai S; Koma A; Kikkawa N; Kato M; Kasamatsu A; Uzawa K; Hanazawa T; Seki N
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886008
[TBL] [Abstract][Full Text] [Related]
55. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
56. MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting the PDCD4.
Cheng Y; Xiang G; Meng Y; Dong R
Reprod Biol; 2016 Sep; 16(3):225-233. PubMed ID: 27476679
[TBL] [Abstract][Full Text] [Related]
57. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
[TBL] [Abstract][Full Text] [Related]
58. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
[TBL] [Abstract][Full Text] [Related]
59. Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines.
Aarthy R; Rao AKDM; Patel K; Sridevi V; Rajkumar T; Gowda H; Mani S
Mol Biol Rep; 2022 Jan; 49(1):821-826. PubMed ID: 34727290
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
Zhang R; Xia T
Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
